Early LMR Dynamics and AFP Status in Advanced HCC Treated With Atezolizumab/Bevacizumab. Omori M, Komatsu S, Tada T, Ishihara N, et al. Anticancer Res 2026;46:5119-5127.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Omori M, Komatsu S, Tada T, Ishihara N, et al. Early LMR Dynamics and AFP Status in Advanced HCC Treated With Atezolizumab/Bevacizumab. Anticancer Res 2026;46:5119-5127.
PMID: 42674689